Quantifications of 10 polycyclic aromatic hydrocarbons (PAHs) and 13 aliphatic hydrocarbons (AHs) ranging from n- C20 to n- C32 were reported in 17 homes and their adjacent outdoor environment in Hong Kong. It was found that PAHs were predominantly associated with PM1.9, which contributed about 98 and 97% to the indoor and outdoor PM10 PAHs, respectively. Also, indoor PAH levels seemed to be lower than outdoor PAH levels, both in the fine mode and in the coarse mode particles. The mean total PAH content in the indoor PM10 was found to be 3.42 ng·m–3 and it was 5.18 ng·m–3 in the outdoor PM10. It might demonstrate that there was no presence of indoor PAH sources in these homes. In contrast to PAH, AH levels were found to be higher indoors both in the fine mode and in the coarse mode particles. In addition, the concentrations of indoor and outdoor AH were significantly higher than their corresponding PAH levels. The mean total AH content in the indoor PM10 was 104.42 ng·m–3 and 94.06 ng·m–3 in the outdoor PM10. For PM1.9, the total indoor AH content was 80.40 ng·m–3 and the outdoor content was 70.55 ng·m–3 on average. The distribution patterns of the indoor and outdoor AHs were similar, with maximum AH concentration varying from n- C27 to n- C31. The carbon preference indexes, which ranged from 0.84 to 2.62 for indoor and from 1.13 to 3.89 for outdoor environment, indicate the mixed origin of biogenic and anthropogenic sources in these homes.

Keywords:
Polycyclic aromatic hydrocarbons, Aliphatic hydrocarbons, Particulates
This content is only available via PDF.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.